Luminex s Randy Marfin on the Advantages of Beads Over Planar Arrays | GenomeWeb

At A Glance

Name: Randel Marfin

Position: Vice president of business development at Luminex


A report released in August by BioPerspectives consulting company showed that within the protein arrays market, bead arrays are growing at twice the rate of planar arrays. ProteoMonitor caught up with the vice president of business development at Luminex, the leading bead array manufacturer, to find out more about why beads are thriving in the market.

Can you give some history of Luminex as a bead company?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.